New foam could ease painful skin condition

NCT ID NCT07077902

Recruiting now Disease control Sponsor: Tulane University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a medicated foam (roflumilast) applied to the skin for hidradenitis suppurativa, a painful inflammatory condition. Ten adults will use the foam alone or with their usual treatments for 4 months. Researchers will check if it improves symptoms and analyze skin gene changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: topical roflumilast 0.3% foam
What this could lead to: If it works, this could offer a new topical option to control hidradenitis suppurativa, reducing flares and improving symptoms.
What could go wrong: This is a very small early-phase study with only 10 people, so results may not apply broadly. The treatment may not work or could cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIDRADENITIS SUPPURATIVA

Contacts and locations

Locations

LCMC Multi-speciality Clinic
RECRUITING

New Orleans, Louisiana, 70112, United States
Lakeside Hospital
RECRUITING

New Orleans, Louisiana, 70001, United States
Lakeview Hospital
RECRUITING

Covington, Louisiana, 70433, United States
University Medical Center
RECRUITING

New Orleans, Louisiana, 70112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.